Cancer is a complex disease characterized by genetic mutations. These mutations can influence how a person's body responds to cancer treatments, such as chemotherapy, targeted therapy, and immunotherapy. Pharmacogenomics aims to identify these genetic variations to optimize treatment plans, minimize adverse effects, and improve the overall efficacy of cancer therapies.
